未登录.png)
分享.png)
收藏Joint Association of Lipoprotein(a) and a Family History of Coronary Artery Disease with the Cardiovascular Outcomes in Patients with Chronic Coronary Syndrome
Liu, Hui -Hui; Li, Sha; Zhang, Yan; Guo, Yuan-Lin; Zhu, Cheng-Gang; Wu, Na-Qiong; Gao, Ying; Xu, Rui-Xia; Dong, Qian; Li, Jian-Jun 分享 收藏 The effect of lipid-lowering therapy on lipid-related residual risk factors: a prospective studyLi, Zhifan; Gao, Yanan; Lu, Qianhong; Yin, Zheng; Zhang, Shuang; Zhang, Wenjia; Sui, Yonggang; Xu, Yanlu; Li, Jianjun; Dou, Kefei; Qian, Jie; Qiu, Hong; Wu, Naqiong 分享 收藏 Chinese Expert Consensus on the Clinical Diagnosis and Management of Statin IntoleranceLi, Jian-Jun; Dou, Ke-Fei; Zhou, Zhi-Guang; Zhao, Dong; Ye, Ping; Chen, Hong; Chen, Zhen-Yue; Peng, Dao-Quan; Guo, Yuan-Lin; Wu, Na-Qiong; Qian, Jie 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Rationale and design of a randomized controlled trial: The effect of intensive lipid-lowering therapy with PCSK9 inhibitor on endothelial-coverage of stent strut after percutaneous coronary intervention (PCI) for patients with acute coronary syndrome (ACS): Optical coherence tomography (OCT) study (PIECES-OCTYin, Zheng; Li, Zhi-Fan; Zhang, Wen-Jia; Zhang, Shuang; Sui, Yong-Gang; Xu, Yan-Lu; Zhang, Hai-Tao; Liu, Xiao-Ning; Qiu, Hong; Zhao, Jing-Lin; Li, Jian-Jun; Dou, Ke-Fei; Qian, Jie; Wu, Yong-Jian; Wu, Na-Qiong 分享 收藏 The Effects of Sacubitril/Valsartan Compared to Olmesartan on the Blood Pressure and Glucolipid Metabolism in DM Patients with Primary HypertensionZhang, Shuang; Yin, Zheng; Li, Zhi-Fan; Zhang, Wen-Jia; Sui, Yong-Gang; Xu, Yan-Lu; Zhang, Hai-Tao; Liu, Xiao-Ning; Qiu, Hong; Zhao, Jing-Lin; Li, Jian-Jun; Dou, Ke-Fei; Qian, Jie; Wu, Na-Qiong 分享 收藏 分享 收藏 Long-term clinical outcomes of percutaneous coronary intervention for ostial left main coronary artery diseaseSui, Yonggang; Qian, Jie; Guan, Changdong; Xu, Yanlu; Wu, Naqiong; Yang, Weixian; Wu, Yongjian; Dou, Kefei; Yang, Yuejin; Qiao, Shubin; Xu, Bo 分享 收藏 Long Noncoding RNA TPRG1-AS1 Suppresses Migration of Vascular Smooth Muscle Cells and Attenuates Atherogenesis via Interacting With MYH9 ProteinRen, Xiaoxiao; Zhu, Huijuan; Deng, Keyong; Ning, Xiaotong; Li, Lin; Liu, Dan; Yang, Bin; Shen, Chenyang; Wang, Xianqiang; Wu, Naqiong; Chen, Shufeng; Gu, Dongfeng; Wang, Laiyuan 分享 收藏 分享 收藏 分享 收藏 Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndromeLiu, Hui-Hui; Guo, Yuan-Lin; Zhu, Cheng-Gang; Wu, Na-Qiong; Gao, Ying; Xu, Rui-Xia; Dong, Qian; Qian, Jie; Dou, Ke-Fei; Li, Jian-Jun 分享 收藏 分享 收藏 Current Guideline Risk Stratification and Cardiovascular Outcomes in Chinese Patients Suffered From Atherosclerotic Cardiovascular DiseaseLi, Sha; Liu, Hui-Hui; Guo, Yuan-Lin; Zhu, Cheng-Gang; Wu, Na-Qiong; Xu, Rui-Xia; Dong, Qian; Qian, Jie; Dou, Ke-Fei; Li, Jian-Jun 分享 收藏 Lipoprotein (a)-mediated vascular calcification: population-based and in vitro studiesPeng, Jia; Liu, Ming-Ming; Liu, Hui-Hui; Xu, Rui-Xia; Zhu, Cheng-Gang; Guo, Yuan-Lin; Wu, Na-Qiong; Dong, Qian; Cui, Chuan-Jue; Li, Jian-Jun 分享 收藏 NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort studyPeng, Jia; Liu, Ming-Ming; Jin, Jing-Lu; Cao, Ye-Xuan; Guo, Yuan-Lin; Wu, Na-Qiong; Zhu, Cheng-Gang; Dong, Qian; Sun, Jing; Xu, Rui-Xia; Li, Jian-Jun 分享 收藏 Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemiaLiu, Ming-Ming; Peng, Jia; Guo, Yuan-Lin; Zhu, Cheng-Gang; Wu, Na-Qiong; Xu, Rui-Xia; Dong, Qian; Li, Jian-Jun 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
HELIYON.png)
OAAI